Senseonics Holdings, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Senseonics Holdings, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 115% in 3 years, but profit fell: $1,120 less profit per $100 of extra sales. Lower than 96% of Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 94% of Healthcare companies in United States.
- Tangible Net Worth Ratio: Of every $100 of net worth, $99 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 93% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-51.2×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 72% of Healthcare companies in United States.
Cash Locked Ratio
$43For every $100 of sales, $43 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $59 tied up three years earlier.
More money tied up than 85% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
−$1,120Sales grew 115% in 3 years, but profit fell: $1,120 less profit per $100 of extra sales.
Lower than 96% of Healthcare companies in United States.
Asset Productivity Ratio
+115% / -29%In 3 years sales changed by +115% while total assets changed by -29%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-119.2×Operating cash was negative last year, while some debt falls due within a year.
Lower than 86% of Healthcare companies in United States.
Cash Cushion Ratio
+13%Cash, after subtracting all debt, equals 13% of its market value (net cash).
Higher than 55% of Healthcare companies in United States.
Tangible Assets Ratio
100%Of every $100 the company owns, $100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 94% of Healthcare companies in United States.
Tangible Net Worth Ratio
99%Of every $100 of net worth, $99 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 93% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Senseonics Holdings, Inc. made a loss over the last year. Senseonics Holdings, Inc. owes $0.49 for every $1 it owns. Senseonics Holdings, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossSenseonics Holdings, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
4.40The share price is 4.40 times Senseonics Holdings, Inc.'s book value per share, higher than 69% of Healthcare companies in United States.
Market cap
$397 MThe total market value of all of Senseonics Holdings, Inc.'s shares at today's price (share price × number of shares), larger than 52% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$90 MWhat Senseonics Holdings, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.71Net worth divided by the number of shares. The share price of $7.51 is 4.4 times this, which is the P/B above.
Return on equity (ROE)
-118.2%Senseonics Holdings, Inc. lost 118.2% of its shareholders' money over the last year, lower than 75% of Healthcare companies in United States.
Owes vs Owns
0.49×Senseonics Holdings, Inc. owes $0.49 for every $1 it owns (low), higher than 55% of Healthcare companies in United States.
Dividend yield
NoneSenseonics Holdings, Inc. does not currently pay a dividend.
Revenue growth
+57%Revenue rose 57% in the year to Dec 2025, and grew 29% a year on average over 3 years.
Profit growth
LossSenseonics Holdings, Inc. made a loss in each of the last two years.
Profit margin
-196.0%Senseonics Holdings, Inc. lost $196 for every $100 of revenue.
Interest cover
Not coveredSenseonics Holdings, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashSenseonics Holdings, Inc. held $53 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Senseonics Holdings, Inc.: $397 M ÷ $90 M (30 Jun 2026) = 4.4.
What is Senseonics Holdings, Inc.'s return on equity?
Senseonics Holdings, Inc. lost 118.2% of its shareholders' money over the last year, lower than 75% of Healthcare companies in United States.
How much does Senseonics Holdings, Inc. owe compared with what it owns?
Senseonics Holdings, Inc. owes $0.49 for every $1 it owns (low), higher than 55% of Healthcare companies in United States.
Does Senseonics Holdings, Inc. pay a dividend?
No. Senseonics Holdings, Inc. does not currently pay a dividend.
Is Senseonics Holdings, Inc.'s revenue growing?
Revenue rose 57% in the year to Dec 2025, and grew 29% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.